Pfizer will submit full data on Covid treatment pill to the FDA in a few days, CEO says

CNBC News

8 December 2021 - Pfizer CEO Albert Bourla said he’s confident the full results from the clinical trials will show that the oral antiviral pill, Paxlovid, reduces hospitalization and death by 89%.

Pfizer will submit full data on its Covid treatment pill to the FDA in the coming days, CEO Albert Bourla told CNBC on Wednesday.

Read CNBC News article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Timelines , Dossier , COVID-19